Mirus Bio
Fletcher Malcom has a diverse work experience spanning multiple industries. Fletcher is currently the Director of Strategy, Product, and Business Development at Mirus Bio LLC since March 2022. Prior to this, they served as the Head of Product at Nanopareil from March 2021 to March 2022.
From 2011 to 2021, Fletcher worked at Repligen Corporation in various roles. Fletcher started as a Product Line Leader, responsible for the development and commercialization of Repligen's chromatography products. In this role, they successfully introduced the OPUS pre-packed chromatography columns into clinical and commercial drug manufacturing. Fletcher then became the Director of Product Management from 2016 to 2018 and the Associate Director Product & Marketing Manager from 2014 to 2015. Prior to that, they held the position of Product & Marketing Manager from 2011 to 2013.
Before joining Repligen Corporation, Fletcher briefly worked as a Market Research Consultant at Blue Stream Laboratories in 2011. Fletcher also pursued their MBA at Babson College, F.W. Olin Graduate School of Business from 2009 to 2011.
In the earlier stages of their career, Fletcher served as a Chemistry Consultant at Waters Corporation from 2004 to 2009. Fletcher began their professional journey as a Research Assistant and Organic Chemist at Hamilton College in 2002.
Overall, Fletcher Malcom has demonstrated expertise in strategy, product development, product management, and marketing, working in the biotechnology and pharmaceutical sectors.
Fletcher Malcom obtained their Bachelor of Arts degree in Chemistry from Hamilton College from 1999 to 2003. Fletcher then went on to earn their Master of Business Administration (MBA) degree from Babson F.W. Olin Graduate School of Business, specializing in the Managing Technology Intensive Enterprises (MTIE) Track, from 2009 to 2011. Prior to their college education, Fletcher Malcom attended Dover-Sherborn High School from 1996 to 1999.
This person is not in any offices
Mirus Bio
1 followers
Mirus Bio Corporation, a life science company, discovers, develops, and commercializes nucleic acid based technologies and products. It provides transfection reagents, electroporation kits and solutions, DNA and RNA labeling reagents, in vivo delivery products, and accessories. The company offers its products through distributors in Argentina,Australia, Austria, Belgium, Bangladesh, Canada, Chile, the People's Republic of China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Japan, Korea, Malaysia, the Netherlands, New Zealand, Norway, the Philippines, Portugal, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, the United Kingdom, the United States, and Vietnam. Mirus Bio Corporation was formerly known as Mirus Corporation. The company was founded in 1995 and is based in Madison, Wisconsin. As of September 30, 2008, Mirus Bio Corporation operates as a subsidiary of Roche Holding AG.